C
Cameron C. Trenor
Researcher at Boston Children's Hospital
Publications - 72
Citations - 3905
Cameron C. Trenor is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Thrombosis & Stroke. The author has an hindex of 24, co-authored 70 publications receiving 2992 citations. Previous affiliations of Cameron C. Trenor include Harvard University & University of Cincinnati.
Papers
More filters
Journal ArticleDOI
Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies
Denise M. Adams,Denise M. Adams,Cameron C. Trenor,Adrienne M. Hammill,Adrienne M. Hammill,Alexander A. Vinks,Alexander A. Vinks,Manish N. Patel,Manish N. Patel,Gulraiz Chaudry,Mary Sue Wentzel,Paula S. Mobberley-Schuman,Lisa M. Campbell,Christine Brookbank,Anita Gupta,Anita Gupta,Carol Chute,Jennifer Eile,Jesse McKenna,Arnold C. Merrow,Arnold C. Merrow,Lin Fei,Lindsey Hornung,Michael Seid,A. Roshni Dasgupta,A. Roshni Dasgupta,Belinda H. Dickie,Belinda H. Dickie,Ravindhra G. Elluru,Anne W. Lucky,Brian Weiss,Brian Weiss,Richard G. Azizkhan +32 more
TL;DR: Sirolimus was efficacious and well tolerated in these study patients with complicated vascular anomalies and clinical activity was reported in the majority of the disorders.
Journal ArticleDOI
Lymphatic and Other Vascular Malformative/Overgrowth Disorders Are Caused by Somatic Mutations in PIK3CA
Valerie L. Luks,Nolan Kamitaki,Matthew P. Vivero,Wibke Uller,Rashed Rab,Judith V.M.G. Bovée,Kristy L. Rialon,Carlos J. Guevara,Ahmad I. Alomari,Arin K. Greene,Steven J. Fishman,Harry P.W. Kozakewich,Reid A. Maclellan,John B. Mulliken,Reza Rahbar,Samantha A. Spencer,Cameron C. Trenor,Joseph Upton,David Zurakowski,Jonathan A. Perkins,Andrew L Kirsh,James T. Bennett,William B. Dobyns,Kyle C. Kurek,Matthew L. Warman,Matthew L. Warman,Matthew L. Warman,Steven A. McCarroll,Rudy Murillo +28 more
TL;DR: Most individuals from Boston Children's Hospital who had isolated LM or LM as part of a syndrome were somatic mosaic for PIK3CA mutations, with 5 specific PIK 3CA mutations accounting for ∼ 80% of cases.
Journal ArticleDOI
Kaposiform Hemangioendothelioma: Atypical Features and Risks of Kasabach-Merritt Phenomenon in 107 Referrals
Stacy E. Croteau,Marilyn G. Liang,Harry P.W. Kozakewich,Ahmad I. Alomari,Steven J. Fishman,John B. Mulliken,Cameron C. Trenor +6 more
TL;DR: An enlarging cutaneous lesion is the most common presenting feature of KHE in infancy and the risk of KMP increases dramatically when tumor infiltrates muscle or when KHE arises in the retroperitoneum or mediastinum.
Journal ArticleDOI
The G185R mutation disrupts function of the iron transporter Nramp2
TL;DR: The G185R mutation causes near total loss of Nramp2 function that cannot be fully explained by a decreased amount of protein, indicating that G 185R disrupts iron transport through an alteration in the function of NRamp2, rather than degradation of the protein.
Journal ArticleDOI
Consensus-derived practice standards plan for complicated Kaposiform hemangioendothelioma.
Beth A. Drolet,Cameron C. Trenor,Leonardo R. Brandão,Yvonne E. Chiu,Robert H. Chun,Roshni Dasgupta,Maria C. Garzon,Adrienne M. Hammill,Craig M. Johnson,Brook E. Tlougan,Francine Blei,Michèle David,Ravindhra G. Elluru,Ilona J. Frieden,Sheila Fallon Friedlander,Ionela Iacobas,John N. Jensen,David M. King,Margaret T. Lee,Stephen C. Nelson,Manish N. Patel,Elena Pope,Julie Powell,Marcia Seefeldt,Dawn H. Siegel,Michael E. Kelly,Denise M. Adams +26 more
TL;DR: In this article, a consensus-derived standard of practice for the treatment of Kaposiform Hemangioendothelioma (KHE) with and without associated Kasabach-Merritt phenomenon (KMP) was developed.